Altria Group, Inc.
MO
$0.00
-0.77%
Altria Group, Inc. is a leading tobacco company in the United States, operating in the Consumer Defensive sector. It is defined by its dominant market position in cigarettes and smokeless tobacco, anchored by the Marlboro brand, and is strategically diversifying into reduced-risk products and other investments.…
MO
Altria Group, Inc.
$0.00
Related headlines
Investment Opinion: Should I buy MO Today?
Based on a synthesis of the available data, the objective assessment for MO is a Hold. The stock offers a compelling 7.2% dividend yield backed by strong free cash flow, and its valuation multiples (P/E ~14) appear reasonable. However, these positive factors are counterbalanced by the existential threat of industry decline, mixed success in strategic pivots, and complex financial statement distortions. The stock is likely suitable only for income-focused investors with a high tolerance for sector-specific risk and a long-term horizon, not for growth-oriented portfolios.
Sign up to view all
MO 12-Month Price Forecast
The analysis yields a neutral stance. The high, well-covered dividend and reasonable valuation provide a floor, but the overwhelming secular headwinds and lack of a clear growth engine create a ceiling. The probability-weighted outlook suggests limited total return potential over the next 12 months, primarily consisting of the dividend.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Altria Group, Inc.'s 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
3 analysts
Implied Upside
—
vs. current price
Analyst Count
3
covering this stock
Price Range
$0 - $0
Analyst target range
No sufficient analyst coverage available. The provided data includes recent rating actions from individual firms (e.g., UBS 'Buy', Barclays 'Underweight'), but a comprehensive consensus target price, ratings distribution, or sufficient number of analyst estimates (only 3 analysts provided EPS estimates) is not available for a definitive summary.
Bulls vs Bears: MO Investment Factors
MO presents a classic value-income dichotomy. The bull case rests on its high yield, strong cash generation, and defensive market position. The bear case focuses on the secular decline of its core business, transition risks, and complex financial metrics. The stock's recent rally to near its 52-week high adds near-term valuation pressure.
Bullish
- High Dividend Yield: 7.2% yield is exceptionally high and well-supported by strong free cash flow.
- Strong Market Position: Dominant share in US cigarettes with Marlboro brand (40% share).
- Attractive Valuation: Forward P/E of 11.4 and trailing P/E of 13.9 suggest moderate valuation.
- Robust Free Cash Flow: TTM FCF of $9.07B provides stability and supports shareholder returns.
Bearish
- Structural Industry Decline: Core cigarette business faces secular decline and regulatory pressure.
- Smoke-Free Transition Struggles: News highlights challenges in reduced-risk product portfolio.
- Weak Balance Sheet Metrics: Negative ROE (-198%) and D/E (-7.34) due to accounting distortions.
- Low Short-Term Liquidity: Current ratio of 0.61 indicates potential liquidity constraints.
MO Technical Analysis
Overall Assessment: The stock has exhibited significant volatility over the past six months, declining sharply in late October 2025 before staging a strong recovery into late February 2026. The 3-month performance is notably positive at +14.45%, significantly outperforming the broader market (SPY -4.63%). Short-term Performance: Over the past month, the stock has declined by -4.42%, slightly outperforming the SPY's -5.25% drop, as indicated by a positive 1-month relative strength of 0.83. The 3-month gain of +14.45% is robust, driven by a rally from a low near $54 in early January to a peak near $70 in late February. Current Position: The current price of $65.99 sits approximately 93.5% of the 52-week high ($70.51) and is 25% above the 52-week low ($52.82), indicating it is trading near the upper end of its annual range following the recent rally.
Beta
0.43
0.43x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$53-$71
Price range past year
Annual Return
+11.4%
Cumulative gain past year
| Period | MO Return | S&P 500 |
|---|---|---|
| 1m | -4.7% | -3.7% |
| 3m | +13.6% | -4.1% |
| 6m | -0.4% | -2.1% |
| 1y | +11.4% | +16.1% |
| ytd | +14.3% | -3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MO Fundamental Analysis
Revenue & Profitability: Q4 2025 revenue of $5.85 billion showed strong year-over-year growth of 14.5%. However, profitability metrics were mixed; the Q4 net margin was 19.1%, a significant decline from the 59.5% net margin in Q4 2024, primarily due to a large one-time tax benefit in the prior year. The trailing twelve-month net margin is a healthy 34.5%. Financial Health: The company's debt-to-equity ratio is negative (-7.34), a common accounting artifact for firms with significant retained earnings deficits, which complicates traditional leverage assessment. Free cash flow generation remains strong at $9.07 billion TTM, supporting the dividend. Operational Efficiency: Return on Equity (ROE) is deeply negative at -198.4%, again distorted by negative shareholder equity. Return on Assets (ROA) is positive at 27.3%, indicating efficient use of assets to generate profit. The current ratio of 0.61 suggests a relatively low level of short-term liquidity.
Quarterly Revenue
$5.8B
2025-12
Revenue YoY Growth
+0.14%
YoY Comparison
Gross Margin
+0.62%
Latest Quarter
Free Cash Flow
$9.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MO Overvalued?
Valuation Level: With positive net income, the trailing P/E ratio of 13.9 is the primary valuation metric. This suggests the stock is trading at a moderate earnings multiple. The forward P/E of 11.4, based on analyst estimates, indicates expectations of earnings growth. Peer Comparison: Data not available for direct industry average comparisons. However, the stock's dividend yield of 7.2% is exceptionally high, and its EV/EBITDA of 10.9 provides another perspective on its enterprise value relative to operating profit.
PE
13.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -8x~81x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.9x
Enterprise Value Multiple
Investment Risk Disclosure
MO faces significant fundamental and market risks. The primary risk is the structural, long-term decline of the combustible tobacco industry, exacerbated by ongoing regulatory pressures and public health initiatives. The company's transition to reduced-risk products (like NJOY and On nicotine pouches) remains challenging, as noted in recent news, creating uncertainty around future growth drivers. Financially, while cash flow is strong, the balance sheet shows distortions with negative shareholder equity, leading to misleading traditional leverage and return metrics. The low current ratio (0.61) indicates limited liquidity cushion. Market risks include high short interest (short ratio 5.86), which can amplify volatility, and the stock's sensitivity to interest rate changes given its high-dividend profile. The recent 3-month rally of over 14% has pushed the stock to 93.5% of its 52-week high, increasing near-term vulnerability to a pullback.
FAQ
The key risks are: 1) Secular Decline: The core cigarette business faces long-term volume erosion due to health concerns and regulation. 2) Transition Risk: The company's pivot to reduced-risk products (vaping, heated tobacco, pouches) is unproven and competitive. 3) Financial Distortions: Negative shareholder equity distorts ROE (-198%) and D/E (-7.34) ratios. 4) Dividend Sustainability: While currently supported by $9.07B in TTM FCF, prolonged earnings pressure could threaten the payout. 5) High Short Interest: A short ratio of 5.86 indicates persistent bearish sentiment.
The 12-month outlook is range-bound with a high degree of uncertainty. The base case (60% probability) sees the stock trading between $60 and $70, offering the dividend as the primary return. The bull case (25%) could see a breakout to $75 if its smoke-free transition gains traction. The bear case (15%) risks a fall toward the 52-week low of $52 if fundamentals deteriorate sharply. The consensus view is for minimal capital appreciation, with the 7.2% yield constituting the bulk of total return.
Based on traditional earnings multiples, MO appears fairly valued to slightly undervalued. Its trailing P/E of 13.9 and forward P/E of 11.4 are moderate. However, the stock is trading at 93.5% of its 52-week high ($70.51) following a strong rally, which limits near-term upside. The high dividend yield of 7.2% also suggests the market prices in significant risk, counterbalancing the modest P/E. A holistic view suggests it is fairly valued at current levels.
MO is a good buy only for a specific type of investor: one seeking high current income (7.2% yield) who is comfortable with the structural decline of the tobacco industry and the associated risks. Its valuation (forward P/E of 11.4) is not demanding, and cash flow supports the dividend. For growth-oriented or risk-averse investors, it is not a compelling purchase given the lack of a clear growth catalyst and significant secular headwinds.
MO is suitable only for a long-term, income-oriented investment horizon. Short-term trading is challenged by the stock's low beta (0.43) but high volatility driven by news and dividend dates. The long-term holder is betting that the company's cash flows can sustain the dividend for years despite industry decline. This requires patience and a focus on yield, not capital gains. It is not suitable for short-term investors seeking quick growth.